Literature DB >> 4116776

Low-dose heparin after myocardial infarction.

A J Handley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4116776     DOI: 10.1016/s0140-6736(72)93016-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  14 in total

1.  Editorial: Low-dose heparin and the prevention of venous thromboembolic disease.

Authors: 
Journal:  Br Med J       Date:  1975-08-23

Review 2.  The venous thrombotic risk in nonsurgical patients.

Authors:  J Bouthier
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism.

Authors:  V V Kakkar
Journal:  World J Surg       Date:  1978-01       Impact factor: 3.352

Review 4.  Thromboembolism. Diagnosis and treatment.

Authors: 
Journal:  West J Med       Date:  1974-03

5.  Heparin therapy, deep-vein thrombosis and pulmonary embolism after intracerebral hemorrhage.

Authors:  U Dickmann; E Voth; H Schicha; T Henze; H Prange; D Emrich
Journal:  Klin Wochenschr       Date:  1988-12-01

6.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

7.  Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials.

Authors:  R Collins; S MacMahon; M Flather; C Baigent; L Remvig; S Mortensen; P Appleby; J Godwin; S Yusuf; R Peto
Journal:  BMJ       Date:  1996-09-14

8.  Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking.

Authors:  P A Emerson; P Marks
Journal:  Br Med J       Date:  1977-01-01

Review 9.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

10.  Venous thromboembolic events in hospitalised medical patients.

Authors:  Gregory Piazza; John Fanikos; Maksim Zayaruzny; Samuel Z Goldhaber
Journal:  Thromb Haemost       Date:  2009-09       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.